He XY - Search Results

1

Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.

Spicer ST, Ha H, Boyd RA, He XY, Carter N, Tran G, Penny MJ, Hodgkinson SJ, Hall BM. Spicer ST, et al. Among authors: he xy. J Immunol. 2001 Oct 1;167(7):3725-33. doi: 10.4049/jimmunol.167.7.3725. J Immunol. 2001. PMID: 11564788

2

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4.

Tran GT, Carter N, He XY, Spicer TS, Plain KM, Nicolls M, Hall BM, Hodgkinson SJ. Tran GT, et al. Among authors: he xy. Int Immunol. 2001 Sep;13(9):1109-20. doi: 10.1093/intimm/13.9.1109. Int Immunol. 2001. PMID: 11526091

3

Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokines.

Plain KM, Fava L, Spinelli A, He XY, Chen J, Boyd R, Davidson CL, Hall BM. Plain KM, et al. Among authors: he xy. Transplantation. 1997 Dec 15;64(11):1559-67. doi: 10.1097/00007890-199712150-00009. Transplantation. 1997. PMID: 9415556

4

Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses.

He XY, Chen J, Verma N, Plain K, Tran G, Hall BM. He XY, et al. Transplantation. 1998 May 15;65(9):1145-52. doi: 10.1097/00007890-199805150-00001. Transplantation. 1998. PMID: 9603159

5

Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.

Plain KM, Chen J, Merten S, He XY, Hall BM. Plain KM, et al. Among authors: he xy. Transplantation. 1999 Feb 27;67(4):605-13. doi: 10.1097/00007890-199902270-00020. Transplantation. 1999. PMID: 10071035

6

CD4(+), CD25(+) T cells as regulators of alloimmune responses.

Chen J, Huoam C, Plain K, He XY, Hodgkinson SJ, Hall BM. Chen J, et al. Among authors: he xy. Transplant Proc. 2001 Feb-Mar;33(1-2):163-4. doi: 10.1016/s0041-1345(00)01956-4. Transplant Proc. 2001. PMID: 11266760 No abstract available.

7

Interleukin 12 delays allograft rejection: effect mediated via nitric oxide.

Verma N, He XY, Chen J, Robinson C, Boyd R, Tran G, Hall BM. Verma N, et al. Among authors: he xy. Transplant Proc. 2001 Feb-Mar;33(1-2):416-7. doi: 10.1016/s0041-1345(00)02074-1. Transplant Proc. 2001. PMID: 11266890 No abstract available.

8

IL-5 prolongs allograft survival by downregulating IL-2 and IFN-gamma cytokines.

He XY, Verma N, Chen J, Robinson C, Boyd R, Hall BM. He XY, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):703-4. doi: 10.1016/s0041-1345(00)02212-0. Transplant Proc. 2001. PMID: 11267027 No abstract available.

9

Interleukin 13 cloning from DA rats.

He XY, Verma N, Plain K, Hall BM. He XY, et al. Transplant Proc. 1999 May;31(3):1572-3. doi: 10.1016/s0041-1345(99)00042-1. Transplant Proc. 1999. PMID: 10331006 No abstract available.

10

Cloning and expression of interleukin-5 from rats.

He XY, Verma N, Chen J, Plain K, Hall B. He XY, et al. Transplant Proc. 1999 May;31(3):1574-6. doi: 10.1016/s0041-1345(99)00043-3. Transplant Proc. 1999. PMID: 10331007 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

791 results

Search Page

Filters